CGIC ETF Analysis

本页由 AI 从英文原文机器翻译而来；以英文版本为准。阅读英文版本

仅供参考。不构成财务建议。

快速解答

CGIC ETF has a last stored price of $36.09, as of the Oct 2, 2026 trading session. Holdings and weights below are as of Mar 15, 2026.

In the stored portfolio snapshot, the largest listed holding is Taiwan Semiconductor Manufacturing Co Ltd ADR (TSM) at 5.19%.

CGIC ETF — Price, Holdings & Analysis

ETF 概览

CGIC aims to provide investors with a concentrated portfolio of international stocks. The fund achieves this by investing in a small number of carefully selected companies. Its top holdings reflect a focus on technology and healthcare, with significant allocations to Taiwan Semiconductor Manufacturing Co Ltd ADR (5.19%), ASML Holding NV (2.30%), and Samsung Electronics Co Ltd (2.08%). Other notable holdings include AstraZeneca PLC (2.01%) and BAE Systems PLC (1.90%). This concentrated approach can lead to higher potential returns but also increased risk compared to more diversified international equity ETFs. The fund's strategy is suited for investors seeking targeted exposure to specific global companies and sectors, potentially as a complement to a broader, more diversified portfolio. Past performance does not guarantee future results.

风险指标

CGIC's presents a significant concentration risk. A decline in the performance of even one of its top holdings, such as Taiwan Semiconductor Manufacturing (5.19%), could have a substantial negative impact on the fund's overall performance. The fund's sector allocation also contributes to its risk profile, with a notable emphasis on technology and healthcare companies. The ETF's beta of 0.00 suggests it has historically exhibited very low volatility relative to the market. Past performance does not guarantee future results.

Beta: 0.00

CGIC持有哪些资产？

持仓	权重
Taiwan Semiconductor Manufacturing Co Ltd ADR (TSM)	5.19%
ASML Holding NV (ASML.AS)	2.30%
Samsung Electronics Co Ltd (005930.KS)	2.08%
AstraZeneca PLC (AZN.L)	2.01%
BAE Systems PLC (BA.L)	1.90%
British American Tobacco PLC (BATS.L)	1.50%
TotalEnergies SE (TTE.PA)	1.46%
UniCredit SpA (UCG.MI)	1.36%
Koninklijke KPN NV (KPN.AS)	1.33%

持仓及权重截至2026年3月15日。该基金数据已超过45天；请向发行人核实当前持仓。

股息率

0.00%

常见问题

What is CGIC and what does it track?

CGIC is an ETF that provides investors with exposure to a concentrated portfolio of international equities. Unlike broad-based international ETFs, CGIC invests in a very limited number of companies.

This focused approach allows investors to target specific global companies and sectors.

What are the top holdings in CGIC?

CGIC's top holdings are concentrated in a small number of international companies.

As of 2026-03-15, the top three holdings are Taiwan Semiconductor Manufacturing Co Ltd ADR (TSM) at 5.19%, ASML Holding NV (ASML.AS) at 2.30%, and Samsung Electronics Co Ltd (005930.KS) at 2.08%. Other significant holdings include AstraZeneca PLC (AZN.L) at 2.01% and BAE Systems PLC (BA.L) at 1.90%.

Is CGIC a good long-term investment?

Whether CGIC is a suitable long-term investment depends on an investor's individual risk tolerance and investment objectives. The fund's presents both opportunities and risks.

The potential for higher returns exists if the fund's top holdings perform well, but the concentration also increases the risk of significant losses if those companies underperform.

How does CGIC compare to similar ETFs?

CGIC distinguishes itself from similar international equity ETFs through its highly concentrated portfolio. This concentrated approach can lead to different performance outcomes compared to more diversified ETFs. Without expense ratio or AUM data, a full comparison is not possible.

Does CGIC pay dividends?

As of 2026-03-15, CGIC has a dividend yield of 0.00%. This indicates that the fund is not currently distributing any dividend income to its shareholders.

Investors seeking income from their investments may want to consider other ETFs with higher dividend yields. However, it's important to note that dividend yields can fluctuate over time and are not guaranteed. Past performance does not guarantee future results.

免责声明：本内容仅供参考，不构成投资建议。请始终自行研究并咨询专业财务顾问。

数据仅供参考。

本页由机器撰写，未逐页经过人工审阅。编辑把关是系统性的：我们检查规则与数据来源，但不检查每一个页面。